Home » Tenders » Europe » Germany » Open House Contracts for Several Active Ingredients / Active Ingredient Combinations Tender

Open House Contracts for Several Active Ingredients / Active Ingredient Combinations Tender

Download Documents

AOK NORDWEST - THE HEALTH INSURANCE COMPANY has floated a tender for Open House Contracts for Several Active Ingredients / Active Ingredient Combinations. The project location is Germany and the tender is closing on 30 Sep 2022. The tender notice number is 556424-2020, while the TOT Ref Number is 47728231. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Open House Contracts for Several Active Ingredients / Active Ingredient Combinations

Deadline : 30 Sep 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 47728231

Document Ref. No. : 556424-2020

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK NORDWEST - THE HEALTH INSURANCE COMPANY
Address: Copenhagener Str. 1
Town: Dortmund
NUTS code: DEA - NORTH RHINE-WESTPHALIA
Postal Code: 44269
Germany
Email :openhouse@nw.aok.de
URL :www.aok.de

Tender Details

Document Type: Contract notice

Title: Open house contracts for several active ingredients / active ingredient combinations

Reference Number: 2020-11-17-NW-KRA-Open House

Contract Type: Supplies

Description: The subject of this publication is the conclusion of contracts in accordance with Section 130a, Paragraph 8 of Book V of the Social Code on the following active ingredients / active ingredient combinations in the context of a so-called open house procedure:

- Formoterol & Beclomethasone (R03AK08),

- Ambrisentan (C02KX02),

- Chlorprothixen (N05AF03),

- Biperiden (N04AA02),

- Paracetamol (N02BE01),

- Ebastine (R06AX22),

- Tramadol & Paracetamol (N02AJ13),

- infliximab (L04AB02).

All suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the conclusion of a discount agreement in accordance with Section 130a (8) SGB V for the above-mentioned active ingredients / active ingredient combinations under standard contractual conditions and a standardized access procedure.

The earliest contract start is 1/1/2021. Based on this, the contract term is a maximum of 24 months.

33600000 - Pharmaceutical products

Authority Type: Body govern ...